In line with this hypothesis, treatment of ATM-deficient mice with scavengers of reactive oxygen species (ROS) alleviates the lymphocyte developmental defects observed in these mice, as well as the development of thymic lymphomas [13]. This evidence concerns the gene ATM and thymus lymphoma.